Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-24

Clinical Trial Update: Comprehensive Program for Hereditary Transthyretin Amyloidosis

View source ↗

Summary

Clinical trial update announcing a comprehensive program for hereditary transthyretin amyloidosis that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital de Alta Complejidad en Red | Conditions: Amyloidosis in Transthyretin (TTR), Amyloidosis, Familial | Status: RECRUITING